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We have used the carbon dioxide (CO2) laser and the gallium aluminium arsenide (GaAIAs)
diode laser with flexible fiber delivery instruments for vaporization of the inferior nasal
turbinate in pediatric patients since 1993. Under endoscopic control, the whole inferior
turbinate was vaporized by 5-10W laser output delivered via an optical fiber. Generally, the
nasal mucosa changes into normal mucosa, and symptoms improve. The greatest sympto-
matic improvement was in nasal obstruction. The results obtained by the two laser devices
were similar although they have had different characteristics. Endoscopic laser surgery is
effective in the treatment of pediatric nasal allergy.
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INTRODUCTION
Nasal allergy can be treated by surgical procedures
such as inferior turbinectomy. However, it is dif-
ficult in children due to bleeding, discomforting
nasal packing, difficulty in the selection of anesthe-
sia, etc. On the other hand, laser devices have been
effective for otolaryngologic surgery for allergic
rhinitis in adults [1-6]. In pediatric cases, however,
the laser technique needs to be modified with smal-
ler instruments. We have used the carbon dioxide
(CO2) laser and the gallium aluminium arsenide
(GaA1As) diode laser with a flexible fiber delivery
system for vaporization of the inferior nasal
turbinate in pediatric patients. Table I indicates
some of the common characteristics of two laser
devices. The CO2 laser is known for its long wave-
length and shallow penetration depth. The diode
laser has a short wavelength and deep penetration
depth. Allergic reactions occur in the epithelial
layer. By cauterizing only the surface of the nasal
mucosa, the CO2 laser would be suitable to treat
nasal allergy. In hemorrhagic cases, however, the
diode laser would be more suitable for treatment.
Since previous studies, have not compared CO
TABLE Comparative study of surgical lasers
CO Diode
Wavelength(nm) 10 600 805
Absorbance by water Large Small
Absorbance by hemoglobin Small Small
Absorbance by blood Large Small
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and diode laser devices in terms of treatment for
allergic rhinitis, this study attempts to evaluate them
in terms of therapeutic effect.
METHODS
The procedures were performed on 22 patients, 13
boys and 9 girls, ranging in age from 9 to 15 years
(mean 12.4). Fifteen patients were treated with the
CO2 laser device, and 7 were with diode laser device.
From 1993 to 1996, the CO2 laser device was
employed, and in 1997, the diode laser device was
employed. All patients were given diagnoses of
allergic rhinitis with multiple allergens based
on results of radioallergosorbency tests. No drug
treatment had been effective in any patient. Patients
with other nasal diseases such as chronic sinusitis
were excluded from the study.
In order to determine the optimum laser power,
we studied the relationships between the laserpower
and the penetration depth in nasal mucosa after
vaporization with both lasers at various power
levels (1-10W) for 0.5 s. Figure indicates that
the penetration depth of the CO2 laser at from 2
to 9W was approximately 0.6mm. Figure also
indicates a similar depth of penetration with the
diode laser with CO2 laser (0.6mm) producing
from 7W up. Because of these results, we chose
6-10W power for diode laser treatment.
The patients underwent preoperative infiltrative
anesthesia using small pieces of gauze impreg-
nated with 4% lidocaine and 0.02% epinephrine.
Neither general anesthesia nor hospitalization was
required.
Using the CO2 laser device (Mochida Pharma-
centical Co. Ltd., Tokyo, Japan), the surgeon can
have a flexible optical fiber with a diameter of
2.3mm (Fig. 2). For non-contact mode procedures,
a 5-7W, continuous mode, defocused laser beam
was delivered. Using the diode laser device (Diomed,
Cambridge, UK), the surgeon can use a flexible
fiber with a diameter of 0.4mm (Fig. 3). For con-
tact mode procedures, a 6-10W, continuous mode,
defocused laser beam was employed.
All laser procedures were performed under endo-
scopic monitoring via a video system. The diameters
of the endoscopes were 4 and 2.7mm. This system
including the built-in filter for the diode laser was
FIGURE 2 The disposable flexible optical fiber for the de-
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FIGURE Relationship between the laser power and the
penetration depth in human nasal mucosa.
FIGURE 3 A flexible quartz fiber for the defocused diode
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TABLE II Patients questionnaire
How do you usually 1. Always through the nose
breathe? (nasal obstruction) 2. No mouth breathing
3. Sometimes through the mouth
4. Always through the mouth
How many times a day 1. None
do you blow your nose? 2. Less than 5
(nasal discharge) 3.5-9
4. More than 9
How many times a day 1. None
do you sneeze? 2. Less than 5
3.5-9
4. More than 9
FIGURE 4 Seven watt continuous mode CO laser beam
was used for the surgery.
assembled by Olympus Optical Co. (Tokyo, Japan).
Eye protection for the observers was not necessary
with the monitoring video system.
To evaluate overall improvement, all patients
filled in a questionnaire before and more than 2
weeks after the procedure (Table II). In the eval-
uation of nasal obstruction, grades 4 and 3 mean
that the patient had marked symptoms. Grade 2
indicates slight symptoms, and grade indicates
no symptoms. Rhinorrhea was evaluated by the
number of times they blew their noses per day. The
evaluation of sneezing was the same as that for
rhinorrhea. The symptomatic improvements were
classified as excellent (preoperative score minus
post-treatment score grades=2), good (1),
unchanged, and worse. Percent improvement was
calculated to compare CO2 and diode laser treat-
ments: Percent improvement 100 [(excellent
response cases + good response cases)/total num-
ber]. Statistical differences ofpercent improvements
between CO2 and diode laser groups were evaluated
by2 test.
RESULTS
Typical changes after laser treatment are shown
in Fig. 4. A 13-year-old girl with allergic rhinitis had
a chief complaint of nasal obstruction. Preopera-
tively the mucosa of the inferior turbinate was pale
and edematous. Under endoscopic control, the
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FIGURE 5 Comparison of percent improvement after sur-
gery between the CO2 and the diode laser in 22 patients.
NS no significant difference.
laser using a power output of 7 W, anteriorly then
posteriorly and then inferiorly. By 2 weeks after
the laser treatment, the mucosal color had become
normal, and the edema of the inferior turbinate
improved.
Figure 5 indicates percent improvements of three
symptoms after laser treatment in 22 patients.
Concerning symptoms of nasal obstruction, 12 out
of 22 showed excellent results (54.5%), 7 showed
good results (31.8%), 3 were unchanged (13.6%),
and none showed a worse result (0%). Concerning
improvement of sneezing, 8 out of 22 showed
excellent results (36.4%), 7 showed good results
(31.8%), 6 were unchanged (27.3%), and showed
a worse result (4.5%). Concerning improvement of
nasal discharge, 4 out of22 showed excellent results
(18.2%), 11 showed good results (50.0%), 7 were192 S. ARAKI et al.
unchanged (31.8%), and none worsened (0%).
Percent improvement of nasal obstruction (86.4%)
was higher than the other two symptoms. There was
no significant difference between the CO2 and the
diode laser groups (nasal obstruction: Z2_ 0, P
0.999; nasal discharge: 2__ 0.072, P --0.789; sneez-
ing:2 0.072, P 0.789). There were no complica-
tions, such as postoperative bleeding, after the laser
procedure.
DISCUSSION
Lippert and Werner [6] compared the results of
inferior turbinectomy in children and adults
between the CO2 and neodymium:yttrium-alumi-
num-garnet lasers (Nd:YAG). Their study indi-
cated that both lasers were useful tools for the
reduction of hyperplastic inferior nasal turbinates.
The present study in children showed similar results
in the treatment of allergic rhinitis. Lippert and
Werner [6] reported that postoperative care after
Nd:YAG laser therapy takes longer than that
following CO2 laser treatment. Because of more
similar characteristics of the diode laser and the
Nd:YAG laser, we thought that postoperative
care after diode laser procedure might be difficult
in children. However, the present result showed no
significant difference between CO2 and diode laser
treatment. Figure indicated that similar depths
of vaporization (0.6mm) were produced with the
diode laser and with the CO2 laser at power output
levels from 7 to 10W. This is related to the similar
clinical results obtained.
One of the differences between the previously
reported Nd:YAG laser treatment and our diode
laser treatment was the laser power. We chose a
lower power of 10W or less. On the other hand,
Lippert and Werner [6] employed higher power
(5-30 W). High power results in extensive and deep
vaporization, and may damage the periosteum.
If the diode laser were applied at a power of over
10W, the tissue may be vaporized deeply, and
postoperative bleeding or crust formation may
continue for a long time.
There was no case of postoperative complication
in our treatment. Low laser power and accurate
vaporization produce less bleeding, and prevent
adhesion of nasal mucosa. Endoscopy is therefore
necessary for the procedure. In conclusion, endo-
scopic laser treatment for pediatric allergic rhinitis
is effective and safe.
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